Award

Delivery Order #SPE2DR26FF3E8

Delivery Order for Ondansetron Tablets under Pharmaceutical IDV

Buyer

Defense Logistics Agency

Award Amount

$2,854.79

Ceiling

$2,854.79

Awarded

February 13, 2026

Period of Performance

Feb 13, 2026 – Feb 17, 2026

Identifier

SPE2DR26FF3E8

NAICS

424210

This contract award is a delivery order contract executed under a broader indefinite delivery vehicle (IDV) with AmerisourceBergen Drug Corp, a leading pharmaceutical distributor. The award involves the procurement of Ondansetron ODT 4 mg tablets, a medication commonly used to prevent nausea and vomiting caused by chemotherapy. This delivery order supports the agency’s ongoing pharmaceutical supply needs and ensures timely access to essential medications. The scope of work specifically includes the delivery of the Ondansetron tablets within a short-term performance window. The delivery order was issued as part of a multi-year IDV contract awarded to AmerisourceBergen, highlighting a sustained partnership for pharmaceutical services. This procurement appears to be executed under a competitive contract vehicle previously awarded to AmerisourceBergen, leveraging their extensive distribution capabilities. The contract period is brief, illustrating a specific, immediate need fulfillment, with the order to be performed in Conshohocken, PA. There is no indication of sole-source justification, suggesting this delivery order follows established contract terms within the IDV framework. The parent IDV contract reinforces this award’s significance by providing a stable supply chain foundation for pharmaceuticals over many years, impacting both healthcare providers and patient care continuity.

Description

4570834611!ONDANSETRON ODT 4 MG TABLET 30S

View original record